Expression of 11β-hydroxysteroid dehydrogenase types 1 and 2 in colorectal cancer

Cancer Letters

Volumn 210, Issue 1, 2004, Pages 95-100

  Žbánková, Šárka ^a,b   Bryndová, Jana ^b   Kment, Milan ^a   Pácha, Jiří ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

11 Hydroxysteroid dehydrogenase; Cancer; Colon

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; MESSENGER RNA; UNCLASSIFIED DRUG; CORTISONE; HYDROCORTISONE; ISOENZYME;

ADULT; AGED; ARTICLE; COLON ADENOCARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; ADENOCARCINOMA; COLORECTAL TUMOR; COMPARATIVE STUDY; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

MAMMALIA;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; CORTISONE; FEMALE; HUMANS; HYDROCORTISONE; ISOENZYMES; MALE; MIDDLE AGED; RNA, MESSENGER;

EID: 2542462090     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.12.019     Document Type: Article

References (29)

1. Berrada A., Denis M.G., Blanchardie P., Chadeneau C., Lustenberger P. Glucocorticoid effects and receptors in two rat colon carcinoma cell lines differing by their tumorigenicity. J. Steroid Biochem. Mol. Biol. 37:1990;223-230
2. Lointier P., Wildrick D.M., Boman B.M. The effects of steroid hormones on human colon cancer cell line in vitro. Anticancer Res. 12:1992;1327-1330
3. Braunschweiger P.G., Ting H.L., Schiffer L.M. Correlation between glucocorticoid receptor content and the antiproliferative effect of dexamethasone in experimental solid tumors. Cancer Res. 43:1983;4757-4761
4. Arisawa Y., Sutanto-Ward E., Fortunato L., Sigurdson E.R. Hepatic artery dexamethasone infusion inhibits colorectal hepatic metastases: a regional antiangiogenic therapy. Ann. Surg. Oncol. 2:1995;114-120
5. Meyer A.S., Schmidt T.J. Potential mechanisms underlying autoregulation of glucocorticoid receptor mRNA levels in the DHD/K12/PROb rat colonic adenocarcinoma cell line. J. Steroid Biochem. Mol. Biol. 55:1995;219-228
6. Brentani M.M., Liberato M.H., Macedo T.M., Habr-Gama A., Laudanna A.A. Steroid receptors in Brazilian patients with large bowel cancer. Braz. J. Med. Biol. Res. 26:1993;277-284
7. McCawley L.J., Matrisian L.M. Tumor progression: Defining the soil round the tumor seed. Curr. Biol. 11:2001;R25-R27
8. Rabbitt E.H., Lavery G.G., Walker E.A., Cooper M.S., Stewart P.M., Hewison M. Prereceptor regulation of glucocorticoid action by 11β-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation. FASEB J. 16:2002;36-44
9. Stewart P.M., Krozowski Z.S. 11β-hydroxysteroid dehydrogenase. Vit. Horm. 57:1999;249-324
10. Whorwood C.B., Ricketts M.L., Stewart P.M. Epithelial cell localization of type 2 11β-hydroxysteroid dehydrogenase in rat and human colon. Endocrinology. 135:1994;2533-2541
11. Smith R.E., Maguire J.A., Stein-Oakley A.N., Sasano H., Takahashi K., Fukushima K., Krozowski Z.S. Localization of 11β-hydroxysteroid dehydrogenase type II in human epithelial tissues. J. Clin. Endocrinol. Metab. 81:1996;3244-3248
12. Takahashi K., Sasano H., Fukushima K., Hirasawa G., Miura H., Sasaki I., et al. 11β-hydroxysteroid dehydrogenase type II in human colon cancer: a new marker of fetal development and differentiation in neoplasms. Anticancer Res. 18:1998;3381-3388
13. Pácha J., Lisá V., Mikšík I. Effect of cellular differentiation on 11β-hydroxysteroid dehydrogenase activity in the intestine. Steroids. 67:2002;119-126
14. Ferrari P., Smith R.E., Funder J.W., Krozowski Z.S. Substrate and inhibitory specificity of the cloned human 11β-hydroxysteroid dehydrogenase type 2 isoform. Am. J. Physiol. 270:1996;E900-E904
15. Albiston A.L., Obeyesekere V.R., Smith R.E., Krozowski Z.S. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 105:1994;R11-R17
16. +-dependent 11β hydroxysteroid dehydrogenase (11β-HSD-3). Steroids. 62:1997;444-450
17. Pohlová I., Mikšík I., Kuneš J., Pácha J. 11β-hydroxysteroid dehydrogenase activity in spontaneously hypertensive and Dahl rats. Am. J. Hypertens. 13:2000;927-933
18. Whorwood C.B., Mason J.I., Ricketts M.L., Howie A.J., Stewart P.M. Detection of human 11β-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts. Mol. Cell. Endocrinol. 110:1995;R7-12
19. Kreuzer K.A., Lass U., Landt O., Nitsche A., Laser J., Ellerbrok H., et al. Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of β-actin transcripts as quantitative reference. Clin. Chem. 45:1999;297-300
20. Hundertmark S., Bühler H., Rudolf M., Weitzel H.K., Ragosch V. Inhibition of 11β-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticosteroids on MCF-7 and ZR-75-1 breast cancer cells. J. Endocrinol. 155:1997;171-180
21. Bland R., Worker C.A., Noble B.S., Ryre L.J., Bujalska I.J., Sheppard M.C., Hewison M. Characterization of 11β-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines. J. Endocrinol. 161:1999;455-464
22. Rabbitt E.H., Ayuk J., Boelaert K., Sheppard M.C., Hewison M., Stewart P.M., Gittoes N.J. Abnormal expression of 11β-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation. Oncogene. 22:2003;1663-1667
23. Mune T., Morita H., Suzuki T., Takahashi Y., Isomura Y., Tanahashi T., et al. Role of local 11β-hydroxysteroid dehydrogenase type 2 expression in determining the phenotype of adrenal adenomas. J. Clin. Endocrinol. Metab. 88:2003;864-870
24. Albertin G., Tortorella C., Malendowicz L.K., Aragona F., Neri G., Nussdorfer G.G. Human adrenal cortex and aldosterone secreting adenomas express both 11β-hydroxysteroid dehydrogenase type 1 and type 2 genes. Int. J. Mol. Med. 9:2002;495-498
25. Mazzocchi G., Malendowicz L.K., Aragona F., Tortorella C., Gottardo L., Nussdorfer G.G. 11β-hydroxysteroid dehydrogenase types 1 and 2 are up- and downregulated in cortisol-secreting adrenal adenomas. J. Invest. Med. 50:2002;288-292
26. Sasano H., Frost A.R., Saitoh R., Matsunaga G., Nagura H., Krozowski Z.S., Silverberg S.G. Localization of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II in human breast and its disorders. Anticancer Res. 17:1997;2001-2008
27. Thieringer R., LeGrande C.B., Cai T.-Q., Wong B., Wright S.D., Hermanowski-Vosatka A. 11β-hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages. J. Immunol. 167:2001;30-35
28. Maser E. Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer. Trends Pharmacol. Sci. 18:1997;270-275
29. Eberhardt W., Schulze M., Engels C., Klasmeier E., Pfeilschifter J. Glucocorticoid-mediated suppresion of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells. Involvement of nuclear factor kappa-B and ets transcription factors. Mol. Endocrinol. 16:2002;1752-1766